Draerofit 50/100 Capsule is a combination dry powder inhaler formula used for the long-term management of Asthma and Chronic Obstructive Pulmonary Disease (COPD). It contains 50 mcg of Salmeterol and 100 mcg of Fluticasone Propionate. Dr. Best Pharmaceuticals Pvt. Ltd. manufactures this inhaler capsule in accordance with GMP standards.
As a long-acting Bronchodilator, Salmeterol relaxes the muscles in the airways. This allows them to open, improve airflow, and make breathing easier. Fluticasone Propionate is an Inhaled Cortico-Steroid (ICS) that reduces inflammation in the airways. Together, they help manage Asthma symptoms and prevent COPD flare-ups by improving lung function.
Salmeterol and Fluticasone are an FDA-approved combination (popular under the brand name Advair Diskus) for the maintenance treatment of Asthma and COPD. However, Draerofit 50/100 Capsule is not for immediate relief of acute symptoms during an Asthma attack. For rescue relief, a fast-acting inhaler like Albuterol should be used.
It is typically prescribed for daily use, 1 capsule inhaled once or twice daily using a Dry Powder Inhaler (DPI). Do not skip doses and take it consistently, even when symptoms are not apparent. If you miss a dose, take it as soon as possible unless it's close to the next one. Never double up or exceed the prescribed amount.
Common side effects of Draerofit 50/100 Capsule include throat irritation, hoarseness, cough, and oral fungal infections. Rinsing the mouth after use helps reduce the risk of these side effects. Seek immediate medical attention if breathing worsens, white patches appear in the mouth, or you experience severe allergy symptoms.
Draerofit 50/100 Capsule should not be used by individuals with a known hypersensitivity to Salmeterol or Fluticasone. Special monitoring is recommended for individuals with heart conditions, Hypertension, Diabetes, Osteoporosis, active infections, or Glaucoma.
Store at room temperature (20°C-25°C), away from heat and moisture. Keep out of the reach of children.
Draerofit 50/100 Capsule offers several therapeutic benefits for patients with pulmonary conditions. These include:
Draerofit 50/100 Capsule should be taken using a dry powder inhaler device. Follow these steps to take it correctly:
Draerofit 50/100 Capsules are available in Salmeterol (50 mcg) and Fluticasone Propionate (100 mcg) formulation. Cheap Medicine Shop offers other substitutes in easy-to-use inhalers as well, such as:
| Seroflo 25 mcg/50 mcg Inhaler | $ 21.83/1 inhaler |
| Seretide 25 mcg/125 mcg Evohaler | $ 23.88/1 inhaler |
Draerofit 50/100 Capsule may cause side effects during treatment. These include:
Most side effects are mild and temporary. However, if these symptoms persist or worsen, or if you experience breathing difficulty, chest tightness, or allergic reactions, seek immediate medical attention. Moreover, long-term use may require monitoring for potential effects on bone density, eye pressure, potassium levels and adrenal suppression.
Liver Disease
Due to the Fluticasone component, Salflute should be used cautiously in patients with liver disease. The medication may stay in the body longer; thus, regular monitoring of liver function is recommended.
Kidney Impairment
No dose adjustment is necessary for mild kidney impairment, but Salflute should be used with caution in patients with Chronic Kidney Failure.
Pregnant and Breastfeeding women
Draerofit Capsules are generally considered safe for use during pregnancy when the doctor determines that the potential benefits outweigh the risks. Breastfeeding mothers should consult their doctors before use, as the medication might pass into breast milk.
Avoid
Do not use if you are allergic to Salmeterol, Fluticasone, or any other ingredient in the capsule. Avoid grapefruit juice and alcohol, as these can increase the likelihood of side effects. Do not combine with blood pressure medicines, beta-blockers or antiarrhythmics. Never stop taking Salflute 50/100 Capsule abruptly, as it may worsen Asthma symptoms. Since it is an immunosuppressive therapy, avoid exposure to those with the flu, colds, or chickenpox.
Draerofit 50/100 Capsule works by relaxing the airway muscles with Salmeterol and reducing inflammation with Fluticasone Propionate. This helps prevent flare-ups and manage chronic breathing difficulties in COPD.
No, Salmeterol Fluticasone capsule is not intended to be used as a rescue inhaler for immediate relief during an Asthma attack. It is a maintenance treatment that helps control Asthma symptoms over time. For quick relief, use a rescue inhaler containing Salbutamol.
While you may start seeing improvement in symptoms in a few days, noticeable results begin to show after 2 weeks of consistent use. The exact duration of treatment, however, depends on the severity of the condition.
Draerofit 50/100 Capsules are typically to be taken once or twice daily, as prescribed by your pulmonologist. Do not exceed the recommended dosage as it can increase side effects, like vomiting, nausea, dry mouth or throat irritation.
Yes, Draerofit can be used with other COPD or Asthma medications, including rescue inhalers or oral steroids, if prescribed by your doctor. However, inform your healthcare provider about all underlying conditions or other medications you are currently taking.
Yes, one of the side effects of Salmeterol Fluticasone is an increased heart rate or palpitations. While these symptoms usually subside on their own, consult your healthcare provider if they are severe or persistent.
Yes, you should always rinse your mouth after inhaling Draerofit 50/100 Capsule to reduce the risk of fungal infections in your mouth or throat, such as Oral Thrush. Rinse, gargle, and spit out the water to reduce this risk.
Draerofit 50/100 Capsule should be avoided by individuals with a known allergy to Salmeterol, Fluticasone, or other ingredients. Caution is also advised with other medications that affect heart rate or blood pressure, such as beta-blockers or antiarrhythmics. Use in children and pregnant or breastfeeding women should be medically supervised.